Ambu AS (AMBU B):企業の財務・戦略的SWOT分析

◆英語タイトル:Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13067
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ambu AS (AMBU B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The company’s product portfolio includes ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia and the US. Ambu is headquartered in Ballerup, Denmark.

Ambu AS Key Recent Developments

Oct 04,2018: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018
Aug 23,2018: Ambu : Interim report Q3 2017/18
Jun 19,2018: New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken
May 07,2018: Ambu: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)
May 04,2018: Ambu Selects Profisee to Support Data Management Initiatives

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Ambu A/S – Key Facts 6
Ambu A/S – Key Employees 7
Ambu A/S – Key Employee Biographies 8
Ambu A/S – Major Products and Services 9
Ambu A/S – History 14
Ambu A/S – Company Statement 17
Ambu A/S – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 – Company Analysis 20
Company Overview 20
Ambu A/S – Business Description 21
Business Segment: Anaesthesia 21
Overview 21
Performance 21
Business Segment: Patient Monitoring & Diagnostics 21
Overview 21
Performance 21
Business Segment: Visualisation 21
Overview 21
Performance 22
Geographical Segment: Europe 22
Performance 22
Geographical Segment: North America 22
Performance 22
Geographical Segment: Rest of the world 22
Performance 22
R&D Overview 22
Ambu A/S – Corporate Strategy 23
Ambu A/S – SWOT Analysis 24
SWOT Analysis – Overview 24
Ambu A/S – Strengths 24
Ambu A/S – Weaknesses 25
Ambu A/S – Opportunities 26
Ambu A/S – Threats 27
Ambu A/S – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances 36
Ambu A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 36
Ambu A/S, Medical Equipment, Deals By Type, 2013 to YTD 2019 37
Ambu A/S, Recent Deals Summary 38
Section 5 – Company’s Recent Developments 39
Oct 04, 2018: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018 39
Aug 23, 2018: Ambu : Interim report Q3 2017/18 40
Jun 19, 2018: New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken 41
May 07, 2018: Ambu: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018) 42
May 04, 2018: Ambu Selects Profisee to Support Data Management Initiatives 43
Jan 31, 2018: Ambu: Interim report Q1 2017/18 44
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Ambu A/S, Key Facts 6
Ambu A/S, Key Employees 7
Ambu A/S, Key Employee Biographies 8
Ambu A/S, Major Products and Services 9
Ambu A/S, History 14
Ambu A/S, Subsidiaries 18
Ambu A/S, Key Competitors 28
Ambu A/S, Ratios based on current share price 29
Ambu A/S, Annual Ratios 30
Ambu A/S, Annual Ratios (Cont...1) 31
Ambu A/S, Annual Ratios (Cont...2) 32
Ambu A/S, Interim Ratios 34
Ambu A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 36
Ambu A/S, Medical Equipment, Deals By Type, 2013 to YTD 2019 37
Ambu A/S, Recent Deals Summary 38
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

List of Figures
Ambu A/S, Performance Chart (2014 - 2018) 33
Ambu A/S, Ratio Charts 35
Ambu A/S, Medical Equipment, Deals By Year, 2013 to YTD 2019 36
Ambu A/S, Medical Equipment, Deals by Type, 2013 to YTD 2019 37

★海外企業調査レポート[Ambu AS (AMBU B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GAMCO Investors, Inc.:企業の戦略・SWOT・財務情報
    GAMCO Investors, Inc. - Strategy, SWOT and Corporate Finance Report Summary GAMCO Investors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Faurecia S.A.:企業の戦略・SWOT・財務分析
    Faurecia S.A. - Strategy, SWOT and Corporate Finance Report Summary Faurecia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Clovis Oncology Inc (CLVS):医療機器:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Destiny Pharma Plc (DEST):製薬・医療:M&Aディール及び事業提携情報
    Summary Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development of the antibacterial products. The company provides XF drug platform to addre …
  • Targa Resources Partners LP (NGLS PR A):企業の財務・戦略的SWOT分析
    Targa Resources Partners LP (NGLS PR A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Warp Drive Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Warp Drive Bio Inc (Warp Drive) is a natural products provider. The company utilizes the proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform offers solutions to the pharmaceutical opportunities. Warp Drive's integr …
  • SunEdison Inc (SUNEQ)-エネルギー分野:企業M&A・提携分析
    Summary SunEdison, Inc. (SunEdison) is a solar energy company that develops and sells photovoltaic energy solutions, and owns and operates clean power generation assets. The company also develops, manufactures and sells silicon wafer for the semiconductor industry. It also offers solar energy servic …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務情報
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務情報
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Dar Al Dawa Development & Investment Co Ltd (DADI):企業の財務・戦略的SWOT分析
    Dar Al Dawa Development & Investment Co Ltd (DADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Flex Pharma Inc (FLKS):製薬・医療:M&Aディール及び事業提携情報
    Summary Flex Pharma Inc (Flex Pharma) is a clinical-stage biotechnology company that offers discovery and development of innovative and proprietary treatments for muscle cramps, spasms and spasticity connected to the severe neurological diseases of ALS, MS, fibromyalgia, hypomagnesemia, hypocalcemia …
  • M. Dias Branco SA Ind Com de Alimentos:企業の戦略・SWOT・財務情報
    M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report Summary M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Parexel International Corp:医療機器:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • eFFECTOR Therapeutics Inc:企業のM&A・事業提携・投資動向
    eFFECTOR Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eFFECTOR Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆